Sanannen abu ne cewa ɗalibai da yawa suna amfani da abubuwan ƙara kuzari kamar Ritalin da Adderall don haɓaka hankalinsu yayin koyo da haɓaka haɓakarsu. Abin da mutane da yawa ba su sani ba shi ne cewa waɗannan magungunan suna rage yawan aiki lokacin da babu rashin kulawa da rashin hankali.
Masana kimiyya sun ba da mahalarta 40 (shekaru 18 zuwa 35 shekaru) 30 mg methylphenidate (MPH ko Ritalin / Concerta), 15 mg dextroamphetamine (DEX kamar Adderall), 200 mg modafinil (MOD) ko placebo a cikin gwaje-gwaje daban-daban guda hudu.
Gwaji bayan abubuwan kara kuzari
Bayan karbar kashinsu, mahalarta maza na 17 da mata 23 sun yi ayyuka daban-daban don gwada ƙwarewar warware matsalolin su, amsawa, tsara sararin samaniya da ƙwaƙwalwar aiki.
Binciken ya gano cewa shan wadannan "masu wayo" kwayoyi sun rage aikin mahalarta a kan ayyuka masu wahala da warware matsalolin. Magungunan sun haɓaka kwarin gwiwar mahalarta amma sun ƙara yawan lokacin da suka kashe don magance matsala da kashi 50%. inganta aiki."
A yayin da ake ba da magunguna masu kara kuzari, masana kimiyya sun ruwaito cewa kokarin mutane ya karu yayin da ingancin kokarinsu ya ragu, ma'ana sun yi yawa, amma ba a kididdige shawararsu ba.
Babu haɓakar fahimi
A cikin wani rahoto na 2011 da ke nazarin nazarin tasirin abubuwan ƙarfafawa ga mutanen da ba a ba da izini ba, masu bincike a Jami'ar Pennsylvania sun sami sakamako mai ma'ana. Sun yanke shawarar cewa abubuwan kara kuzari na iya inganta koyo kuma, ga wasu, ƙwaƙwalwar aiki. Amma a cikin kashi uku na binciken da suka yi nazari, babu wani daga cikin samari masu lafiya da suka sami ci gaban fahimi tare da magungunan, wasu ma sun sami nakasu. A cikin yin la'akari da rashin amfani da magungunan motsa jiki ta daliban koleji, wani rahoto na 2017 bai sami wani ci gaba na fahimta ba a cikin koyo ko ƙwaƙwalwar ajiya tare da amfani mai mahimmanci idan aka kwatanta da placebo.
Karancin magunguna
45,2%. Wannan shine yadda yawancin matasa masu shekaru 18 zuwa 25 suka yi amfani da magunguna masu kara kuzari a cikin shekarar da ta gabata, a cewar wani rahoto na 2021 daga Shawarar Bayar da Shawarwari da Sabis na Lafiyar Hankali.
Tun daga Oktoba 2022, DEX, wanda a hade tare da amphetamine salts ke yin Adderall, yana cikin jerin abubuwan. magunguna inda daya yake gajere. Hukumar Kula da Abinci da Magunguna (FDA) ta bayyana karuwar bukatar a matsayin dalilin karancin.
Source: Forbes.com (En)
